公开(公告)号：US20160200661A1

公开(公告)日：2016-07-14

申请号：US14914166

申请日：2014-08-26

Applicant: TASLY PHARMACEUTICAL GROUP CO., LTD.

Inventor： Shuiping Zhou ,  Wei Li ,  Yuanpeng Jin ,  Xinxin Li ,  Xiaohui Ma ,  Wei Zhou ,  Min Han ,  Shuming Li

IPC: C07C69/732 ,  C07C67/56

CPC classification number: C07C69/732 ,  A61K36/537 ,  A61K2236/00 ,  C07B2200/09 ,  C07C67/56

Abstract: The present invention relates to the medical field, specifically a salvianolic acid T as described in structural formula (I), a chiral isomer thereof, a preparation method therefor, pharmaceutical compositions, antioxidants, and free radical scavengers thereof, and a use of the compound.

Abstract translation: 本发明涉及医学领域，特别是结构式（I）所述的丹酚酸T，其手性异构体，其制备方法，药物组合物，抗氧化剂及其自由基清除剂，以及该化合物 。

公开(公告)号：US11491173B2

公开(公告)日：2022-11-08

申请号：US16976832

申请日：2019-04-04

Applicant: TASLY PHARMACEUTICAL GROUP CO., LTD.

Inventor： Shuiping Zhou ,  He Sun ,  Yiqian Zhang ,  Xiaohui Ma ,  Jiawen Shi ,  Yi He ,  Xinxin Li ,  Jing Wang ,  Xiaoqing Li ,  Lijun Fan ,  Jingjing Zhang

IPC: A61K31/7048 ,  A61P9/04 ,  A61K31/216 ,  A61K31/343 ,  A61K31/405 ,  A61K31/704

Abstract: Disclosed are a pharmaceutical composition and an application thereof. The pharmaceutical composition of the present invention comprises the following components in parts by weight: 2-20 parts of phenolic acids, 0.5-5 parts of flavonoids, 0.005-0.5 part of tanshinones, 5-20 parts of saponins, and 10-18 parts of volatile oils. The pharmaceutical composition has the functions of protecting against myocardial damage and treating heart failure.